Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-01-17

Clinical Trial Update: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a botanical drug containing East Indian Sandalwood Oil for plaque psoriasis in adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • East Indian Sandalwood Oil (EISO) (East Indian Sandalwood Oil)

Snippet

Sponsor: Santalis Pharmaceuticals, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: WITHDRAWN